Narayana Hrudayalaya Share Price

  • 1,268.952.46 (0.20%)
  • Volume: 6,35,369
  • Closed
  • Last Updated On: 30 Aug, 2024, 03:58 PM IST
Loading...

Narayana Hrudayalaya Sh...

  • 1,268.952.46 (0.20%)
  • Volume: 6,35,369
Advertisment

Narayana Hruday share price insights

View All
  • In the last 8 years, only 1.03 % trading sessions saw intraday declines higher than 5 % .

  • Company delivered ROE of 27.36% in year ending Mar 31, 2024 outperforming its 5 year avg. of 21.03%. (Source: Consolidated Financials)

  • Company has spent 1.93% of its operating revenues towards interest expenses and 20.01% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

  • Stock gave a 3 year return of 147.48% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)

  • Narayana Hrudayalaya Ltd. share price moved up by 0.20% from its previous close of Rs 1,266.50. Narayana Hrudayalaya Ltd. stock last traded price is 1,268.95

    Share PriceValue
    Today/Current/Last1,268.95
    Previous Day1,266.501,265.50

InsightsNarayana Hruday

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    32.15
    EPS - TTM
    (₹)
    39.47
    MCap
    (₹ Cr.)
    25,932.36
    Sectoral MCap Rank
    6
    PB Ratio
    (x)
    8.97
    Div Yield
    (%)
    0.32
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month0.01
    3 Months1.12
    6 Months0.84
    1 Year0.50
    3 Years0.46

    0.01
    VWAP
    (₹)
    1,288.54
    52W H/L
    (₹)
    1,444.90 / 979.95

    Narayana Hruday Share Price Returns

    1 Day0.2%
    1 Week0.36%
    1 Month-0.37%
    3 Months8.69%
    1 Year23.93%
    3 Years139.36%
    5 Years438.26%

    ET Stock ScreenersTop Score Companies

    Check whether Narayana Hruday belongs to analysts' top-rated companies list?

    View Stock Screeners

    Narayana Hruday Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Narayana Hruday Share Recommendations

    Recent Recos

    HOLD

    Current

    Mean Recos by 8 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy

    That's all for Narayana Hruday recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy1111
    Buy4433
    Hold1111
    Sell1111
    Strong Sell11--
    # Analysts8866

    Narayana Hruday Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent 1.93% of its operating revenues towards interest expenses and 20.01% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income1,364.441,303.281,221.521,323.651,248.52
      Total Income Growth (%)4.696.69-7.726.020.99
      Total Expenses1,098.741,049.64987.881,052.411,021.64
      Total Expenses Growth (%)4.686.25-6.133.011.94
      EBIT265.70253.65233.64271.24226.88
      EBIT Growth (%)4.758.56-13.8619.55-3.09
      Profit after Tax (PAT)201.38190.71188.02226.58183.95
      PAT Growth (%)5.591.43-17.0223.176.24
      EBIT Margin (%)19.4719.4619.1320.4918.17
      Net Profit Margin (%)14.7614.6315.3917.1214.73
      Basic EPS (₹)9.929.399.2611.169.06
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income885.41935.70781.16866.00806.24
      Total Income Growth (%)-5.3819.78-9.807.41-4.60
      Total Expenses754.52734.24673.27727.09696.86
      Total Expenses Growth (%)2.769.06-7.404.34-1.06
      EBIT130.89201.46107.89138.92109.39
      EBIT Growth (%)-35.0386.73-22.3326.99-22.29
      Profit after Tax (PAT)86.41158.0978.66108.9378.94
      PAT Growth (%)-45.34100.96-27.7837.99-14.09
      EBIT Margin (%)14.7821.5313.8116.0413.57
      Net Profit Margin (%)9.7616.8910.0712.589.79
      Basic EPS (₹)4.257.783.875.363.89
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue5,093.444,590.213,735.882,610.523,151.57
      Total Revenue Growth (%)10.9622.8743.11-17.179.52
      Total Expenses4,204.913,838.443,297.572,659.752,975.97
      Total Expenses Growth (%)9.5516.4023.98-10.636.98
      Profit after Tax (PAT)789.26606.25341.93-14.30118.92
      PAT Growth (%)30.1977.30--112.03100.98
      Operating Profit Margin (%)19.6318.1413.631.038.34
      Net Profit Margin (%)15.7213.399.23-0.553.80
      Basic EPS (₹)38.8629.8516.85-0.705.86
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue3,389.113,066.032,518.371,730.432,263.49
      Total Revenue Growth (%)10.5421.7545.53-23.558.05
      Total Expenses2,885.662,671.502,312.871,851.412,159.49
      Total Expenses Growth (%)8.0215.5124.92-14.277.17
      Profit after Tax (PAT)424.52265.64133.60-78.6767.74
      PAT Growth (%)59.8198.83--216.1335.26
      Operating Profit Margin (%)17.0714.8210.12-4.686.83
      Net Profit Margin (%)12.998.975.53-4.753.02
      Basic EPS (₹)20.9013.086.58-3.883.34

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets5,624.584,162.093,129.712,770.022,891.06
      Total Assets Growth (%)35.1432.9912.99-4.199.63
      Total Liabilities2,739.492,029.671,640.351,649.201,754.56
      Total Liabilities Growth (%)34.9723.73-0.54-6.0112.80
      Total Equity2,885.092,132.431,489.371,120.821,136.50
      Total Equity Growth (%)35.3043.1832.88-1.385.08
      Current Ratio (x)1.751.311.170.950.98
      Total Debt to Equity (x)0.500.360.370.470.55
      Contingent Liabilities191.75182.26160.9922.6728.90
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets3,492.762,774.722,281.682,100.652,220.17
      Total Assets Growth (%)25.8821.618.62-5.387.03
      Total Liabilities1,652.551,305.981,056.591,011.011,054.29
      Total Liabilities Growth (%)26.5423.604.51-4.1116.30
      Total Equity1,840.211,468.741,225.091,089.641,165.88
      Total Equity Growth (%)25.2919.8912.43-6.54-0.17
      Current Ratio (x)1.170.860.780.600.72
      Total Debt to Equity (x)0.500.370.310.310.32
      Contingent Liabilities188.18151.63772.34414.83315.61

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 1457.94 cr for investing activities which is an YoY increase of 24.18%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities1,066.601,084.56485.02309.05443.35
      Net Cash used in Investing Activities-1,457.94-1,174.10-266.91-112.99-188.54
      Net Cash flow from Financing Activities488.4587.74-158.95-198.43-246.95
      Net Cash Flow97.15-3.9359.02-2.347.86
      Closing Cash & Cash Equivalent241.74144.59148.5389.5191.84
      Closing Cash & Cash Equivalent Growth (%)67.19-2.6565.94-2.548.88
      Total Debt/ CFO (x)1.350.701.121.701.42
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities542.13516.26245.99123.42286.43
      Net Cash used in Investing Activities-760.64-621.23-117.04-11.81-129.00
      Net Cash flow from Financing Activities237.2664.77-56.61-114.26-169.58
      Net Cash Flow18.76-40.2072.34-2.65-12.14
      Closing Cash & Cash Equivalent89.0170.25110.4538.1140.76
      Closing Cash & Cash Equivalent Growth (%)26.70-36.39189.80-6.49-22.95
      Total Debt/ CFO (x)1.701.051.552.711.32

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 27.36% in year ending Mar 31, 2024 outperforming its 5 year avg. of 21.03%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)27.3628.4422.96-1.2710.46
      Return on Capital Employed (%)21.8225.8621.461.2911.38
      Return on Assets (%)14.0314.5610.92-0.514.11
      Interest Coverage Ratio (x)12.6714.8510.380.353.06
      Asset Turnover Ratio (x)1.031.000.9593.22108.18
      Price to Earnings (x)33.2226.1144.64-588.2442.55
      Price to Book (x)9.077.4210.257.414.45
      EV/EBITDA (x)22.1515.7122.7241.3412.47
      EBITDA Margin (%)24.4622.7918.598.1414.28
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)23.0618.0810.90-7.225.81
      Return on Capital Employed (%)19.7320.4513.78-4.778.40
      Return on Assets (%)12.159.575.85-3.743.05
      Interest Coverage Ratio (x)13.2612.969.39-1.783.12
      Asset Turnover Ratio (x)1.041.171.1078.73100.86
      Price to Earnings (x)61.7359.88114.94-106.3875.19
      Price to Book (x)14.2210.7712.457.624.34
      EV/EBITDA (x)37.3427.9542.78189.0219.17
      EBITDA Margin (%)22.0119.5315.042.7412.54

    Financial InsightsNarayana Hruday

    • Income (P&L)
    • Cash Flow
    • Ratios
      • Employee & Interest Expense

        Company has spent 1.93% of its operating revenues towards interest expenses and 20.01% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 1457.94 cr for investing activities which is an YoY increase of 24.18%. (Source: Consolidated Financials)

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 27.36% in year ending Mar 31, 2024 outperforming its 5 year avg. of 21.03%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Narayana Hruday Share Price Forecast

    • PRICE

    • REVENUE

    • EARNINGS

    • Get multiple analysts’ prediction on Narayana Hruday

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Narayana Hruday

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Narayana Hruday

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Narayana Hruday Peer Comparison

    • Narayana Hruday Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of 147.48% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)
      • Stock Returns vs BSE Healthcare

        Stock generated 147.48% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of 147.48% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)
      • Stock Returns vs BSE Healthcare

        Stock generated 147.48% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Narayana Hruday32.158.9927.3621.8214.0324.6819.6315.7338.861.750.501.35
      Fortis Healthcare63.794.877.819.524.5019.1413.979.227.930.450.110.78
      Global Health63.1510.4916.4519.0111.1130.9921.4014.5917.802.440.140.69
      Aster DM Health3.864.042.835.710.71-24.3010.346.022.601.250.154.24
      Krishna Instt of Medical Sciences64.119.6816.9614.918.0523.0320.2913.4638.751.210.572.01
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Rainbow Childrens
      • Jupiter Life Line Hospitals
      • Healthcare Global
      • Yatharth Hospital
      • Artemis Medicare

      Choose from Stocks

      Peers InsightsNarayana Hruday

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of 147.48% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)

      • Stock Returns vs BSE Healthcare

        Stock generated 147.48% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Narayana Hruday Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Narayana Hruday Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters63.8563.8563.8563.85
        Pledge0.000.000.000.00
        FII10.0110.9111.5111.59
        DII8.229.5110.2110.88
        Mutual Funds5.997.187.898.20
        Others17.9215.7214.4313.68
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters13,04,85,73063.85 %0.00
        Pledge00.00 %0.00
        FII2,04,52,41210.01 %-0.90
        DII1,68,05,7648.22 %-1.28
        MF1,22,39,8335.99 %-1.18
        Others3,66,16,89817.92 %2.19

      MF Ownership

      MF Ownership as on 31 July 2024

      Corporate Actions

      • Narayana Hruday Board Meeting/AGM

      • Narayana Hruday Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Aug 02, 2024Jul 29, 2024Board MeetingQuarterly Results
        May 24, 2024May 21, 2024Board MeetingAudited Results & Final Dividend
        Feb 14, 2024Feb 07, 2024Board MeetingQuarterly Results
        Nov 13, 2023Nov 07, 2023Board MeetingQuarterly Results
        Aug 04, 2023May 19, 2023AGM-
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final40%4.0Aug 02, 2024May 24, 2024
        Final25%2.5Jul 07, 2023May 19, 2023
        Final10%1.0Aug 22, 2022May 20, 2022
        Interim10%1.0Mar 11, 2020Feb 27, 2020
        Final10%1.0Aug 01, 2019May 24, 2019
      • No other corporate actions details are available.

      About Narayana Hruday

      Narayana Hrudayalaya Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 25,882.30 Crore) operating in Hospitals & Allied Services sector. Narayana Hrudayalaya Ltd. key Products/Revenue Segments include Income from Medical and Healthcare Services, Medical Equipment and Other Operating Revenue for the year ending 31-Mar-2024. Show More

      • Executives

      • Auditors

      • DP

        Devi Prasad Shetty

        Chairman & Wholetime Director
        VP

        Viren Prasad Shetty

        Exe.Vice Chairman & Whole Time Director
        ER

        Emmanuel Rupert

        Managing Director & Group CEO
        KM

        Kiran Mazumdar Shaw

        Non Executive Director
        Show More
      • Deloitte Haskins & Sells LLP

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times